A review of existing literature examined the mental health effects of contemporary cannabis use across Europe. The researchers focused on how high-potency products containing more than 15 to 25 percent THC affect people's mental well-being. They specifically looked at conditions like psychosis, anxiety, and panic symptoms.
The findings show a consistent link between the use of these high-potency cannabis products and an increased risk of developing psychosis and other mental health issues. The review also noted that many cases are currently missed or not reported in certain regions due to social stigma and inconsistent screening methods.
Because this was a narrative review, the results reflect a summary of existing reports rather than a new clinical trial. It is important to note that data from some areas may be incomplete because of local healthcare differences. These findings suggest that high-potency products and varying health systems can make it harder to manage mental health burdens.
